Director Rossi sells 18,950 shares for $4,953,694.15 in two transactions at $260.49–$262.10; retains 78,691 shares post-sale.
Director Dino A Rossi executed two separate sales on 2026-02-19, disposing of 18,950 shares (19.0K shares) for a combined $4,953,694.15 at a blended average price of $261.41. The reduction represents a 19.4% decrease from his pre-transaction holding of 97,641 shares (97.6K shares), leaving him with 78,691 shares (78.7K shares) post-sale. The sale occurred while the stock is trading at $274.59 current price, approximately 5.9% below its 52-week high of $291.93. Against a strong operational backdrop—Krystal Biotech reported $97.8M in latest-quarter revenue with $79.4M net income and 33.9% annual revenue growth—this material reduction in the director's position represents a significant holding adjustment at valuations that remain well within the stock's recent range.